Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 5,312 shares at $50.72 ($266K) on 2015-03-16, disclosed to the SEC on 2015-03-17.
Scheduled sale ($266k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.08 | 4,650 | $233K | 87.4% |
| 2 | $50.72 | 662 | $34K | 12.6% |
| Total | $50.16 avg | 5,312 | $266K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |